Introduction {#S1}
============

Members of the genus *Pandoraea* have emerged as rare opportunistic pathogens in persons with cystic fibrosis ([@B29]; [@B28]; [@B50]; [@B33]; [@B2]; [@B44]; [@B57]) and several cases of chronic colonization and patient-to-patient transfer in this patient group have been reported ([@B29]; [@B5]; [@B14]; [@B51]; [@B2]; [@B17]; [@B24]). In addition to causing infection in cystic fibrosis patients, *Pandoraea* isolates have been recovered from blood and from samples from patients with chronic obstructive pulmonary disease or chronic granulomatous disease ([@B9]; [@B12]). Although the small number of patients involved and underlying diseases make it difficult to identify these bacteria as the cause of clinical deterioration ([@B44]; [@B23]), one report described sepsis, multiple organ failure and death in a non-cystic fibrosis patient who underwent lung transplantation for sarcoidosis ([@B62]).

Of the 11 validly named *Pandoraea* species, six (i.e., *Pandoraea apista*, *Pandoraea norimbergensis*, *Pandoraea pulmonicola*, *Pandoraea pnomenusa*, *Pandoraea sputorum*, and *Pandoraea fibrosis*) have been recovered from human clinical specimens ([@B9]; [@B57]), while *Pandoraea faecigallinarum*, *Pandoraea oxalativorans*, *Pandoraea terrae*, *Pandoraea thiooxydans*, and *Pandoraea vervacti* have been isolated from environmental samples ([@B3]; [@B54]; [@B26]). An uncultivated endosymbiont of the trypanosomatid *Novymonas esmeraldas* represents an additional *Pandoraea* species which was provisionally named *Candidatus* Pandoraea novymonadis ([@B35]).

A growing number of reports demonstrate that soil and water represent the natural habitats of *Pandoraea* bacteria where they can be part of rhizosphere communities ([@B3]; [@B30]; [@B48]; [@B15]) and be involved in oxalate degradation ([@B27]; [@B54]). The latter suggests they may be important contributors to soil formation, soil fertility and retention, and cycling of elements necessary for plant growth ([@B53]). These free-living *Pandoraea* bacteria are often enriched in polluted soils and participate in the biodegradation of complex organic substances including lignin ([@B58]; [@B39]; [@B42]), biodiesel and petroleum by-products ([@B13]; [@B55]; [@B64]), *p*-xylene ([@B68]), δ-hexachlorocyclohexane ([@B52]), di-*n*-butyl phthalate ([@B70]), biphenyl, benzoate and naphthalene ([@B65]), and tetracycline ([@B69]) and β-lactam antibiotics ([@B11]). A particularly well-documented *Pandoraea* strain, i.e., JB1^T^ (LMG 31106^T^), was isolated in the 1980s from garden soil ([@B47]) and was able to use biphenyl, 2-, 3- and 4-chloro-biphenyl, *m*-toluate, *p*-toluate naphthalene, *m*-hydroxybenzoate and diphenylmethane ([@B60]). Although this strain also represented a separate novel *Pandoraea* species, it was not formally classified ([@B9]) pending the availability of more than one strain representing the same novel species, a taxonomic practice that has been largely abandoned today.

The genome sequences of several strains with bioremediation potential have been reported, but a growing number of studies fail to provide species level identification of such strains ([@B52]; [@B8]; [@B36]; [@B11]; [@B43]; [@B69]). In addition, in our studies on the diversity and epidemiology of opportunistic pathogens in persons with cystic fibrosis, we isolated a considerable number of *Pandoraea* strains that represent novel species (unpublished data). The present study aimed to clarify the taxonomy and formally name these novel *Pandoraea* species, and to make reference cultures and whole-genome sequences of each of these versatile bacteria publicly available.

Materials and Methods {#S2}
=====================

Bacterial Strains and Growth Conditions {#S2.SS1}
---------------------------------------

Isolates representing novel *Pandoraea* species are listed in [Table 1](#T1){ref-type="table"}, along with their isolation source details. These strains were initially assigned to the genus *Pandoraea* on the basis of sequence analysis of 16S rRNA, *gyrB* or *recA* genes (data not shown). Well-characterized reference strains and recent field isolates identified in the present study as established *Pandoraea* species are listed in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. Strains were grown aerobically on Tryptone Soya Agar (Oxoid) and incubated at 28°C. Cultures were preserved in MicroBank^TM^ vials at −80°C.

###### 

Isolates representing novel *Pandoraea* species.

  **Strain**                             **Other strains designations**   **Source**                                 **Depositor**
  -------------------------------------- -------------------------------- ------------------------------------------ ------------------
  ***Pandoraea anapnoica* sp. nov.**                                                                                 
  LMG 31117^T^                           AU1288^T^, CCUG 73385^T^         CF patient (United States, 1999)           Own isolate
  ***Pandoraea anhela* sp. nov.**                                                                                    
  LMG 31108^T^                           AU12140^T^, CCUG 73386^T^        CF patient (United States, 2006)           Own isolate
  ***Pandoraea aquatica* sp. nov.**                                                                                  
  LMG 31011^T^                           CCUG 73384^T^                    Pond water in greenhouse (Belgium, 2013)   Own isolate
  ***Pandoraea bronchicola* sp. nov.**                                                                               
  LMG 20603^T^                           CDC H652^T^, ATCC BAA-110^T^     CF sputum (United States, 1998)            CDC
  R-10961                                AU1775                           CF patient (United States, 2000)           Own isolate
  R-14318                                AU2478                           CF patient (United States, 2000)           Own isolate
  R-52718                                AU17726                          CF patient (United States, 2009)           Own isolate
  ***Pandoraea capi* sp. nov.**                                                                                      
  LMG 20602^T^                           CDC G9805^T^, ATCC BAA-109^T^    Non-CF sputum (United States, 1996)        CDC
  R-15265                                AU2777                           CF patient (United States, 2001)           Own isolate
  R-52714                                AU12983                          CF patient (United States, 2007)           Own isolate
  ***Pandoraea captiosa* sp. nov.**                                                                                  
  LMG 31118^T^                           AU16660^T^, CCUG 73387^T^        CF patient (United States, 2008)           Own isolate
  ***Pandoraea cepalis* sp. nov.**                                                                                   
  LMG 31106^T^                           JB1^T^, CCUG 39680^T^            Garden soil (Netherlands)                  M. Mergeay
  LMG 31107                                                               Soil of house plant (Belgium, 2003)        Own isolate
  R-51030                                                                 Pond water in greenhouse (Belgium, 2013)   Own isolate
  ***Pandoraea commovens* sp. nov.**                                                                                 
  LMG 31010^T^                           CCUG 73378^T^                    CF patient (Belgium, 2002)                 C. De Boeck
  LMG 24770                              AI-S128                          Plant root surface (India, 2002)           M. Madhaiyan
  R-15662                                AU3099                           CF patient (United States)                 Own isolate
  ***Pandoraea communis* sp. nov.**                                                                                  
  LMG 31110^T^                           CCUG 73383^T^                    CF patient (Belgium, 2012)                 D. Pierard
  LMG 31111                                                               River water (Belgium, 2002)                Own isolate
  R-17388                                                                 Maize rhizosphere soil (Belgium, 2002)     Own isolate
  R-20591                                                                 River water (Belgium, 2002)                Own isolate
  ***Pandoraea eparura* sp. nov.**                                                                                   
  LMG 31012^T^                           CCUG 73380^T^                    Soil of house plant (Belgium, 2003)        Own isolate
  ***Pandoraea horticolens* sp. nov.**                                                                               
  LMG 31112^T^                           CCUG 73379^T^                    Garden soil (Belgium, 2003)                Own isolate
  ***Pandoraea iniqua* sp. nov.**                                                                                    
  LMG 31009^T^                           CCUG 73377^T^                    Maize rhizosphere soil (Belgium, 2002)     Own isolate
  LMG 31115                              AU1290                           CF patient (United States, 1999)           Own isolate
  ***Pandoraea morbifera* sp. nov.**                                                                                 
  LMG 31116^T^                           AU12324^T^, CCUG 73389^T^        CF patient (United States, 2006)           Own isolate
  R-54947                                AU23671                          CF patient (United States, 2011)           Own isolate
  ***Pandoraea nosoerga* sp. nov.**                                                                                  
  LMG 31109^T^                           AU17017^T^, CCUG 73390^T^        CF patient (United States, 2008)           Own isolate
  R-12863                                AU2028                           CF patient (United States, 2000)           Own isolate
  R-13299                                00BC460                                                                     P. Evans
  R-15344                                AU2347                           CF patient (United States, 2000)           Own isolate
  R-34565                                                                 CF patient (Australia, 2006)               M. Aravena-Roman
  R-46874                                                                 CF patient (Belgium, 2011)                 G. Ieven
  R-47614                                                                 CF patient (Belgium, 2011)                 H. Franckx
  R-50065                                                                 CF patient (Belgium, 2012)                 G. Ieven
  R-50587                                                                 CF patient (Belgium, 2013)                 C. De Boeck
  R-52720                                AU14034                          CF patient (United States, 2007)           Own isolate
  R-52722                                AU18716                          CF patient (United States, 2009)           Own isolate
  ***Pandoraea pneumonica* sp. nov.**                                                                                
  LMG 31114^T^                           AU18032^T^, CCUG 73388^T^        CF patient (United States, 2009)           Own isolate
  ***Pandoraea soli* sp. nov.**                                                                                      
  LMG 31014^T^                           CCUG 73382^T^                    Soil of house plant (Belgium, 2003)        Own isolate
  ***Pandoraea terrigena* sp. nov.**                                                                                 
  LMG 31013^T^                           CCUG 73381^T^                    Soil of house plant (Belgium, 2003)        Own isolate

CF, cystic fibrosis. LMG, BCCM/LMG Bacteria Collection, Laboratory of Microbiology, Ghent University, Ghent, Belgium; CCUG, Culture Collection University of Gothenburg, Department of Clinical Bacteriology, Sahlgrenska University Hospital, Gothenburg, Sweden; CDC, Centers for Disease Control, United States Public Health Service, Atlanta, GA, United States.

DNA Preparation {#S2.SS2}
---------------

DNA was extracted using an automated Maxwell^®^ DNA preparation instrument (Promega, United States). The final extract was treated with RNAse (2 mg/ml, 5 μL per 100 μL extract) and incubated at 37°C for 1 h. DNA quality was checked using 1% agarose gel electrophoresis and DNA quantification was performed using the QuantiFluor ONE dsDNA system and the Quantus fluorometer (Promega, United States). DNA was stored at −20°C prior to further analysis.

Single Locus Sequence Analyses {#S2.SS3}
------------------------------

Nearly complete 16S rRNA sequences were obtained as described previously ([@B49]).

Partial *recA* gene sequences (663 bp) were amplified by PCR using forward primer 5′-AGG ACG ATT CAT GGA AGA WAG C-3′ and reverse primer 5′-GAC GCA CYG AYG MRT AGA ACT T-3′ ([@B59]). Each 25 μl PCR reaction consisted of 1x PCR buffer (Qiagen), 1 U of Taq polymerase (Qiagen), 250 μM of each dNTP (Applied Biosystems), 1 × Q-solution (Qiagen), 1 μM of each primer and 2 μl of DNA ([@B49]). PCR was performed using a Veriti 96 Well Thermal Cycler (Applied Biosystems). Initial denaturation for 2 min at 94°C was followed by 30 cycles of 30 s at 94°C, 45 s at 58°C and 1 min at 72°C, and a final elongation for 10 min at 72°C. Amplicons were purified using a NucleoFast 96 PCR clean-up kit (Macherey-Nagel). Sequencing primers (one per sequencing reaction) were the same as the amplification primers. Sequence analysis was performed with an Applied Biosystems 3130xl Genetic Analyzer and protocols of the manufacturer using the BigDye Terminator Cycle Sequencing Ready kit. Sequence assembly was performed using BioNumerics v7.6 (Applied Maths, Belgium).

Partial *gyrB* sequences (573 bp) were amplified by PCR using forward primer 5′-GAC AAY GGB CGY GGV RTB CC-3′ (this study) and reverse primer 5′-YTC GTT GWA RCT GTC GTT CCA CTG C-3′ ([@B59]). The PCR protocol was the same as for *recA*, except that 2 μM of primer was used and an annealing temperature of 60°C. Sequencing primers (one per sequencing reaction) were 5′-ACG ACA AGC ACG ARC CSA AGC G-3′ (this study) and the same reverse primer as for amplification. Sequence analysis and assembly were performed as described above for the *recA* gene.

Partial *gltB* sequences were amplified by PCR using forward primer 5′-CTG CAT CAT GAT GCG CAA GTG-3′ ([@B59]) and reverse primer 5′-GTT GCC ACG GAA RTC GTT GG-3′ (this study). The PCR protocol was the same as for *recA*, except that 0.4 μM of primer was used. Sequencing primers (one per sequencing reaction) were the same as the amplification primers. Sequence analysis and assembly were performed as described above for the *recA* gene.

Gene sequences of *recA*, *gyrB*, and *gltB* were aligned based on their amino acid sequences using Muscle ([@B19]) in MEGA7 ([@B37]). Phylogenetic trees were constructed using RAxML v8.2.11 ([@B61]) with the GTRCAT substitution model and 1000 bootstrap analyses. Visualization and annotation of the phylogenetic trees was performed using iTOL ([@B40]).

Whole-Genome Sequencing {#S2.SS4}
-----------------------

The genome sequences of 27 strains ([Table 2](#T2){ref-type="table"} and [Supplementary Table S2](#SM1){ref-type="supplementary-material"}) were determined using the Illumina HiSeq4000 platform (PE150) at the Oxford Genomics Centre. Quality reports were created by FastQC. Reads were trimmed using Trimmomatic ([@B7]) with the MAXINFO:50:0.8 and MINLEN:50 options. Genome size was estimated using kmc ([@B34]) and reads were subsampled with seqtk^[1](#footnote1){ref-type="fn"}^ to 80x coverage depth for assembly. Assembly was performed using SPAdes v3.12.0 ([@B6]) with error correction, default k-mer sizes (21, 33, 55, 77) and mismatch correction. Contigs were filtered on length (minimum 500 bp) and coverage (minimum 0.5x and maximum 8x overall coverage). Raw reads were mapped against the assemblies using bwa mem ([@B41]) and contigs were polished using Pilon 1.22 ([@B67]) with default parameters. Quast ([@B25]) was used to create quality reports of the resulting assemblies. Annotation was performed using Prokka 1.12 ([@B56]) with a genus-specific database based on publicly available genomes.

###### 

Genomes included in the present study.

  **Strain**                               **Project**   **Contigs**   **Size(bp)**   **%GC**   **CDS**   **References**
  ---------------------------------------- ------------- ------------- -------------- --------- --------- ----------------
  *P. apista* DSM 16535^T^                 PRJNA305052   2^*a*^        5,571,260      62.6      4,871     
  *P. apista* LMG 18089                    PRJEB30685    27            5,815,466      62.7      5,279     This study
  *P. apista* AU2161                       PRJNA284212   1^*a*^        5,574,863      62.7      4,655     [@B24]
  *P. apista* TF80G25                      PRJNA281013   1^*a*^        5,609,637      62.6      4,691     [@B24]
  *P. apista* TF81F4                       PRJNA271830   1^*a*^        5,582,097      62.6      4,676     [@B24]
  *P. apista* FDAARGOS_126                 PRJNA231221   1^*a*^        5,326,503      62.7      4,621     
  *P. apista* PA_200                       PRJNA497126   82            5,677,857      62.5      4,969     
  *P. apista* PA_201                       PRJNA497126   69            5,680,846      62.5      4,957     
  *P. apista* Pa13324                      PRJNA507897   132           5,656,881      62.7      4,987     
  *P. apista* Pa14367                      PRJNA441551   97            5,596,190      62.8      4,932     
  *P. apista* Pa14697                      PRJNA507897   107           5,680,889      62.7      4,989     
  *P. apista* Pa15518                      PRJNA507897   106           5,631,909      62.7      4,924     
  *P. apista* Pa15674                      PRJNA507897   208           5,497,617      62.8      4,839     
  *P. apista* Pa16226                      PRJNA381452   23            5,724,490      62.7      4,998     
  *P. apista* Pa16800                      PRJNA507897   171           5,729,367      62.7      5,028     
  *P. apista* Pa17292                      PRJNA507897   113           5,621,546      62.7      4,909     
  *P. apista* Pa18364                      PRJNA507241   130           5,457,038      62.7      4,787     
  *P. apista* Pa18384                      PRJNA507897   136           5,678,267      62.7      4,914     
  *P. apista* Pa18495                      PRJNA507558   124           5,442,190      62.7      4,766     
  *P. apista* Pa18531                      PRJNA507897   143           5,525,740      62.7      4,817     
  *P. faecigallinarum* DSM 23572^T^        PRJNA286722   3^*a*^        5,732,664      63.5      4,858     
  *P. fibrosis* 6399^T^                    PRJNA266749   70            5,574,251      62.9      4,356     [@B20]
  *P. fibrosis* 7641                       PRJNA266765   66            5,574,850      62.9      4,363     [@B20]
  *P. fibrosis* LMG 31113                  PRJEB30745    43            5,605,513      62.8      4,943     This study
  *P. norimbergensis* DSM 11628^T^         PRJNA305058   1^*a*^        6,167,370      63.1      5,237     
  *P. oxalativorans* DSM 23570^T^          PRJNA262701   5^*a*^        6,500,731      63.1      5,400     
  *P. pnomenusa* DSM 16536^T^              PRJNA261997   1^*a*^        5,389,285      64.9      4,586     
  *P. pnomenusa* LMG 31119                 PRJEB30696    46            5,305,298      64.9      4,699     This study
  *P. pnomenusa* 3kgm                      PRJNA226227   1^*a*^        5,429,298      64.7      4,251     
  *P. pnomenusa* E26                       PRJNA229202   96            5,476,952      64.7      4,869     [@B8]
  *P. pnomenusa* MCB032                    PRJNA319140   4^*a*^        5,819,834      64.6      4,872     
  *P. pnomenusa* RB38                      PRJNA242373   1^*a*^        5,378,916      64.8      4,562     
  *P. pnomenusa* RB-44                     PRJNA230133   1^*a*^        5,385,946      64.9      4,646     
  *P. pulmonicola* DSM 16583^T^            PRJNA270151   1^*a*^        5,867,621      64.3      4,868     
  *P. sputorum* DSM 21091^T^               PRJNA262705   1^*a*^        5,742,997      62.8      4,884     
  *P. sputorum* LMG 20601                  PRJEB30706    62            6,264,179      62.7      5,539     This study
  *P. sputorum* LMG 31120                  PRJEB30707    17            5,956,418      62.7      5,301     This study
  *P. sputorum* LMG 31121                  PRJEB30708    113           6,453,978      62.8      5,652     This study
  *P. terrae* LMG 30175^T^                 PRJEB30813    81            6,176,823      62.8      5,575     This study
  *P. thiooxydans* DSM 25325^T^            PRJNA285516   1^*a*^        4,464,186      63.2      3,999     
  *P. thiooxydans* ATSB16                  PRJNA309453   1^*a*^        4,464,185      63.2      4,388     
  *P. vervacti* NS15^T^                    PRJNA275368   2^*a*^        5,736,282      63.5      4,811     
  *P. anapnoica* sp. nov. LMG 31117^T^     PRJEB30755    48            6,126,688      62.4      5,364     This study
  *P. anhela* sp. nov. LMG 31108^T^        PRJEB30724    61            6,046,012      63.4      5,188     This study
  *P. aquatica* sp. nov. LMG 31011^T^      PRJEB30756    17            5,958,127      62.9      5,238     This study
  *P. bronchicola* sp. nov. LMG 20603^T^   PRJEB30725    34            5,351,123      63.0      4,753     This study
  *P. capi* sp. nov. LMG 20602^T^          PRJEB30721    31            5,852,144      63.4      5,056     This study
  *P. capi* sp. nov. ISTKB                 PRJNA325244   115           6,367,971      63.2      5,356     [@B36]
  *P. captiosa* sp. nov. LMG 31118^T^      PRJEB30757    36            6,139,582      63.3      5,340     This study
  *P. cepalis* sp. nov. LMG 31106^T^       PRJEB30715    56            5,274,229      63.7      4,730     This study
  *P. cepalis* sp. nov. LMG 31107          PRJEB30716    32            5,159,566      63.5      4,626     This study
  *P. cepalis* sp. nov. B-6                PRJNA169519   148           5,035,498      63.6      4,570     [@B43]
  *P. commovens* sp. nov. LMG 31010^T^     PRJEB30753    26            6,036,949      62.6      5,308     This study
  *P. communis* sp. nov. LMG 31110^T^      PRJEB30740    17            5,708,603      62.6      5,067     This study
  *P. communis* sp. nov. LMG 31111         PRJEB30741    55            5,566,071      62.5      5,064     This study
  *P. communis* sp. nov. SD6-2             PRJNA174277   37            5,772,015      62.5      5,148     [@B52]
  *P. eparura* sp. nov. LMG 31012^T^       PRJEB30718    35            5,205,577      63.7      4,621     This study
  *P. horticolens* sp. nov. LMG 31112^T^   PRJEB30744    68            6,008,490      62.3      5,378     This study
  *P. iniqua* sp. nov. LMG 31009^T^        PRJEB30748    17            6,339,129      63.1      5,521     This study
  *P. iniqua* sp. nov. LMG 31115           PRJEB30749    14            6,296,634      63.1      5,445     This study
  *P. morbifera* sp. nov. LMG 31116^T^     PRJEB30750    47            5,233,298      64.7      4,676     This study
  *P. nosoerga* sp. nov. LMG 31109^T^      PRJEB30729    41            4,862,114      66.1      4,266     This study
  *P. pneumonica* sp. nov. LMG 31114^T^    PRJEB30747    12            5,845,078      62.5      5,202     This study
  *P. soli* sp. nov. LMG 31014^T^          PRJEB30720    51            4,961,982      63.6      4,395     This study
  *P. terrigena* sp. nov. LMG 31013^T^     PRJEB30719    35            5,356,606      63.5      4,878     This study
  *Pandoraea* sp. PE-S2R-1                 PRJNA385617   189           6,227,302      63.1      5,387     [@B11]
  *Pandoraea* sp. PE-S2T-3                 PRJNA385617   37            6,176,158      63.2      5,310     [@B11]
  *Ca.* Pandoraea novymonadis E262         PRJNA369045   6             1,157,259      43.8      968       [@B35]

a

Status complete.

Publicly Available Genomes {#S2.SS5}
--------------------------

All 41 publicly available (January 29, 2019) whole-genome sequences of *Pandoraea* bacteria were downloaded from the NCBI database ([Table 2](#T2){ref-type="table"}). *Burkholderia cenocepacia* J2315^T^ was used as an outgroup in the phylogenomic analyses. For strains B-6 ([@B43]), E26 ([@B8]), PE-S2R-1 and PE-S2T-3 ([@B11]) no annotation was available and therefore annotation was performed using Prokka as described above.

Phylogenomic Analyses {#S2.SS6}
---------------------

The GBDP approach was used to calculate pairwise digital DNA--DNA hybridization (dDDH) values and their confidence intervals (formula 2) using the Genome-to-Genome Distance Calculator (GGDC 2.1^[2](#footnote2){ref-type="fn"}^) under recommended settings ([@B45]). ANI values were calculated with the OrthoANIu algorithm ([@B71]). Whole-genome phylogeny was assessed based on 107 single-copy core genes found in a majority of bacteria ([@B18]) using bcgTree ([@B4]). Visualization and annotation of the phylogenetic tree was performed using iTOL ([@B40]).

Functional Genome Analyses {#S2.SS7}
--------------------------

To enable a comparative genomic study, each protein-coding gene (CDS) in the 68 *Pandoraea* genomes (*n* = 331,123) was functionally classified using the COG ([@B22]) and KEGG orthologies ([@B32]; [@B31]). COGs were assigned by a reversed position-specific BLAST (RPSBLAST v2.6.0+) with an *e*-value cut-off of 1E-3 against the NCBI conserved domain database (CDD v3.16) ([@B63]). KEGG orthology was inferred using the KEGG automated annotation server (KAAS) ([@B46]). Based on COG and K numbers, each CDS was assigned to the respective COG category and KEGG hierarchy. In case multiple COG categories were defined for the same COG, the first category was considered as the primary category. Protein orthologous groups (orthogroups) were inferred using OrthoFinder v2.2.7 ([@B21]) with default parameters. For each orthogroup, we mapped the genomes and species in which it was present, the specificity (core, multiple species, single species or single isolate), and COG and KEGG functional classification.

Data mapping, visualization and statistical analyses were performed using RStudio with R v3.5.2. Pearson's chi-square analyses were used to test the association between different sets of categorical variables. When a significant relationship was found between two variables, we further examined the standardized Pearson residuals. Standardized Pearson residuals with high absolute values indicate a lack of fit of the null hypothesis of independence in each cell ([@B1]) and thus indicate observed cell frequencies in the contingency table that are significantly higher or lower than expected based on coincidence.

DNA Base Composition {#S2.SS8}
--------------------

The G + C content of all strains was calculated from their genome sequences using Quast ([@B25]).

Biochemical Characterization {#S2.SS9}
----------------------------

Biochemical characterization was performed as described previously ([@B16]).

Fatty Acid Methyl Ester Analysis {#S2.SS10}
--------------------------------

After a 24 h incubation period at 28°C on Tryptone Soya Agar (BD), a loopful of well-grown cells was harvested and fatty acid methyl esters were prepared, separated and identified using the Microbial Identification System (Microbial ID) as described previously ([@B66]).

Results and Discussion {#S3}
======================

Single Locus Sequence Analyses {#S3.SS1}
------------------------------

The 16S rRNA gene sequences determined in the present study are publicly available through the GenBank/EMBL/DDBJ accession numbers listed in the species descriptions. Because the 16S rRNA sequences of *Pandoraea* species show high levels of similarity ([@B9]; [@B12]), *gyrB* gene sequence analysis has been introduced for species level identification of *Pandoraea* isolates ([@B10]). To provide more robust phylogenetic analysis, partial sequences of the *gyrB* gene, and also of the *recA* and *gltB* genes were generated for a total of 84 *Pandoraea* reference strains and field isolates, and were used to construct phylogenetic trees ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM6){ref-type="supplementary-material"}, [S2](#SM7){ref-type="supplementary-material"}). The *gltB*, *gyrB* and *gltB* sequences determined in the present study are publicly available through the GenBank/EMBL/DDBJ accession numbers listed in [Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM6){ref-type="supplementary-material"}, [S2](#SM7){ref-type="supplementary-material"} and in the species descriptions.

![Phylogenetic tree based on partial *gyr*B sequences of all *Pandoraea* strains examined. Sequences (495--573 bp) were aligned based on their amino acid sequences and phylogeny was inferred using the Maximum Likelihood method and GTRCAT substitution model in RAxML. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches if greater than 50%. *Burkholderia cenocepacia* J2315^T^ was used as outgroup. The scale bar indicates the number of substitutions per site. Isolates selected for whole-genome sequencing are shown in bold character type.](fmicb-10-02556-g001){#F1}

Overall, the three phylogenetic trees had comparable topologies, but while taxonomic reference strains of established *Pandoraea* species ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}) and several groups of field isolates formed well-delineated clusters, others did not ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM6){ref-type="supplementary-material"}, [S2](#SM7){ref-type="supplementary-material"}). Each of these phylogenetic trees was therefore used to select a total of 27 isolates (shown in bold character type in [Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM6){ref-type="supplementary-material"}, [S2](#SM7){ref-type="supplementary-material"}) for whole-genome sequence analysis. These included 6 isolates that were tentatively assigned to established *Pandoraea* species using single locus sequence analyses, 20 isolates that clustered separately or whose assignment was equivocal, and *P. terrae* LMG 30175^T^, the sole *Pandoraea* type strain for which there was no publicly available whole-genome sequence at the time of writing.

Genome Characteristics {#S3.SS2}
----------------------

The assembly of the Illumina HiSeq 150 bp paired end reads resulted in assemblies with 12--113 contigs and a total of 4.86--6.45 Mbp ([Table 2](#T2){ref-type="table"} and [Supplementary Table S2](#SM1){ref-type="supplementary-material"}). The number of predicted CDS in the newly sequenced genomes ranged from 4,266 to 5,652 ([Table 2](#T2){ref-type="table"}). No clustered regularly interspaced short palindromic repeats (CRISPRs) were identified. The annotated assemblies of these 27 genomes were submitted to the European Nucleotide Archive and are publicly available through the GenBank/EMBL/DDBJ accession numbers listed in [Table 2](#T2){ref-type="table"} and in the species descriptions. The G + C content of the newly sequenced strains, as calculated from their genome sequences, ranged from 62.3 to 66.1 mol% ([Table 2](#T2){ref-type="table"}). These values are similar those of other *Pandoraea* genomes, except for *Ca.* Pandoraea novymonadis that has a G + C content of 43.8% ([@B35]).

Phylogenomic Analyses {#S3.SS3}
---------------------

The 27 genomes from the present study were compared to all 41 publicly available *Pandoraea* genomes (GenBank database, January 29, 2019), which included 6 unclassified *Pandoraea* strains ([@B52]; [@B8]; [@B11]; [@B38]; [@B43]). Pairwise dDDH and ANI values among the 68 genome sequences were calculated and are listed in [Supplementary Tables S3](#SM2){ref-type="supplementary-material"}, [S4](#SM3){ref-type="supplementary-material"}, respectively. Species delineation based on the 70% dDDH ([@B45]) and 95--96% ANI thresholds ([@B71]) yielded 30 species, which included the 11 validly named species, *Ca.* Pandoraea novymonadis, a total of 17 novel species for which we propose the names shown in [Table 1](#T1){ref-type="table"}, and a novel species represented by strains PE-S2R-1 and PE-S2T-3 ([@B11]) (see below). One of these novel species, i.e., *Pandoraea cepalis*, corresponds with *Pandoraea* genomospecies 1, which we reported earlier ([@B9]). Two novel species, i.e., *Pandoraea capi* and *Pandoraea bronchicola*, correspond with *Pandoraea* genomospecies 3 and 4, respectively, reported by [@B12]. Finally, the phylogenomic data ([Figure 2](#F2){ref-type="fig"} and [Supplementary Tables S3](#SM2){ref-type="supplementary-material"}, [S4](#SM3){ref-type="supplementary-material"}), but also each of the single locus sequence analyses, showed that *Pandoraea* genomospecies 2 LMG 20602 should be classified as *P. sputorum*, which contradicts earlier wet-lab DNA-DNA hybridization results ([@B12]).

![Phylogenetic tree based on 107 single-copy core genes. BcgTree was used to extract the nucleotide sequence of 107 single-copy core genes and to construct their phylogeny by partitioned maximum-likelihood analysis. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. *Burkholderia cenocepacia* J2315^T^ was used as outgroup. Bar, 0.01 changes per nucleotide position.](fmicb-10-02556-g002){#F2}

The use of dDDH and ANI threshold levels was generally straightforward, yet some pairs of strains showed values close to the generally applied taxonomic threshold levels ([Supplementary Tables S3](#SM2){ref-type="supplementary-material"}, [S4](#SM3){ref-type="supplementary-material"}) ([@B45]; [@B71]). The two strains classified as *P. capi* showed 96.4% ANI and 69.6% dDDH with a dDDH confidence interval of 66.6--72.5%, and these strains were therefore classified as the same species. Similarly, the three strains classified as *P. cepalis* showed 96.2--98.4% ANI, 68.4--86.0% dDDH, and the 70% dDDH threshold level was in the confidence interval; these strains were therefore classified as one species. *P. soli* LMG 31014^T^ showed 95.0--95.8% ANI and 60.7--65.0% dDDH toward *P. cepalis* strains, and the 70% dDDH threshold level was not part of the confidence interval, so this strain was classified as a separate species. Similarly, *P. horticolens* LMG 31112^T^ showed 95.0-95.3% ANI and 60.0-62.2% dDDH toward *P. communis*, and the 70% dDDH threshold level was not part of the confidence interval so this strain was also classified as a separate species.

The phylogenomic analyses also allowed us to identify 4 out of 6 unclassified *Pandoraea* strains for which genome sequences are publicly available: strain ISTKB ([@B36]) was assigned to *P. capi*, strain B-6 ([@B43]) to *P. cepalis*, strain SD6-2 ([@B52]) to *P. communis*, and strain E26 ([@B8]) to *P. pnomenusa* ([Figure 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Finally, strains PE-S2R-1 and PE-S2T-3 ([@B11]) formed a separate cluster, which represented yet another novel *Pandoraea* species that remains to be formally classified ([Supplementary Tables S3](#SM3){ref-type="supplementary-material"}, [S4](#SM2){ref-type="supplementary-material"}).

The phylogenomic tree based on 107 single-copy marker genes was well resolved and the clusters delineated by dDDH and ANI formed monophyletic groups with a high bootstrap support ([Figure 2](#F2){ref-type="fig"}). The clades in the phylogenomic tree of the present study showed a branching order similar to a previously published tree based on 119 conserved proteins ([@B35]). The results of the phylogenomic analyses along with the clustering in the individual *recA*, *gyrB*, and *gltB* single locus sequence analyses ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM7){ref-type="supplementary-material"}, [S2](#SM6){ref-type="supplementary-material"}) were used to identify each of the 84 isolates included in the present study. *P. sputorum* strain LMG 31121 clustered with the remaining *P. sputorum* strains in the *gyrB* and *gltB* trees but grouped aberrantly in the *recA* tree. In addition, *P. cepalis* proved particularly difficult to identify through single locus sequence analysis as it exhibited more variation in each of the sequences examined ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figures S1](#SM7){ref-type="supplementary-material"}, [S2](#SM6){ref-type="supplementary-material"}) than any other *Pandoraea* species.

Phenotypic Characterization {#S3.SS4}
---------------------------

The type strains of each of 11 established *Pandoraea* species and of 17 novel *Pandoraea* species reported in the present study were included in an extensive phenotypic characterization. Among *Pandoraea* species, *P. thiooxydans* not only occupies a separate phylogenetic position ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"} and [Supplementary Figures S1](#SM6){ref-type="supplementary-material"}, [S2](#SM7){ref-type="supplementary-material"}) but also has a distinctive phenotype ([Table 3](#T3){ref-type="table"}). While all other *Pandoraea* species show normal growth on general microbiological growth media (i.e., they generate colonies of 1--4 mm in diameter after 2 days of incubation at 37°C), *P. thiooxydans* LMG 24779^T^ requires prolonged incubation up to 7 days before the same colony size was obtained.

###### 

Differential biochemical characteristics of all strains examined.

  **Characteristic**                            **1**   **2**   **3**   **4**   **5**   **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **17**   **18**   **19**   **20**   **21**   **22**   **23**   **24**   **25**   **26**   **27**   **28**
  --------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  Growth at 45°C^*a*^                           −       −       \+      −       −       \+      −       −       −       −        −        \+       −        −        −        \+       −        \+       −        −        −        −        −        −        −        −        −        \+
  Growth at 5% NaCl                             \+      \+      −       \+      \+      \+      \+      \+      −       −        −        −        \+       −        \+       \+       \+       \+       −        \+       \+       \+       −        \+       −        −        −        \+
  Growth at 6% NaCl                             −       −       −       −       −       −       −       −       −       −        −        −        −        −        −        −        \+       −        −        −        −        −        −        −        −        −        −        −
  Growth on MacConkey agar                      \+      \+      \+      \+      \+      \+      \+      \+      \+      \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       −        \+
  Catalase activity                             \+      \+      \+      \+      \+      \+      \+      −       \+      \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+
  Hydrolysis of tween 20                        \+      \+      \+      \+      \+      \+      \+      \+      \+      \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       \+       −        \+       \+       \+
  Hydrolysis of tween 80                        −       −       −       \+      −       −       −       −       −       −        −        −        −        −        \+       −        −        −        −        −        −        −        \+       −        −        −        −        −
  Alkaline phosphatase                          −       w       w       −       w       w       −       −       −       w        −        w        −        −        −        −        w        −        −        −        −        \+       −        −        −        −        −        −
  Acid phosphatase                              \+      \+      \+      \+      w       w       \+      w       \+      \+       w        \+       \+       w        \+       \+       \+       w        w        \+       w        \+       −        −        −        w        \+       \+
  C~4~ esterase activity                        w       w       w       −       \+      \+      w       w       \+      −        w        \+       w        w        \+       w        \+       \+       w        w        −        −        −        −        w        w        \+       w
  Naphtol-AS-BI-β-[D]{.smallcaps}-glucuronide   w       w       w       −       w       w       w       w       −       w        −        \+       −        w        −        w        \+       w        w        w        w        \+       −        w        −        w        \+       w
  Nitrate reduction                             −       −       −       −       −       −       −       \+      \+      −        \+       −        −        −        −        \+       −        −        −        −        \+       −        \+       −        −        \+       \+       −
  Assimilation of [D]{.smallcaps}-glucose       −       −       −       −       −       −       −       −       −       −        −        −        −        −        −        −        \+       −        −        −        −        −        −        −        −        −        w        −
  Assimilation of [D]{.smallcaps}-gluconate     \+      \+      \+      \+      \+      \+      \+      \+      \+      \+       \+       \+       \+       \+       \+       \+       \+       w        −        \+       \+       \+       \+       \+       \+       \+       \+       \+
  Assimilation of caprate                       \+      \+      −       \+      \+      \+      −       −       \+      \+       −        −        \+       \+       w        −        −        −        −        \+       −        \+       −        −        \+       −        −        −
  Assimilation of citrate                       \+      \+      \+      \+      \+      \+      \+      \+      \+      \+       \+       \+       \+       \+       \+       \+       \+       −        \+       \+       \+       \+       \+       \+       \+       \+       \+       \+
  Assimilation of phenylacetate                 \+      \+      \+      \+      \+      \+      \+      \+      \+      \+       \+       \+       \+       \+       \+       \+       \+       −        \+       \+       \+       \+       \+       \+       \+       \+       \+       \+

Species: 1,

P. anapnoica

LMG 31117

T

; 2,

P. anhela

LMG 31108

T

; 3,

P. apista

LMG 16407

T

; 4,

P. aquatica

LMG 31011

T

; 5,

P. bronchicola

LMG 20603

T

; 6,

P. capi

LMG 20602

T

; 7,

P. captiosa

LMG 31118

T

; 8,

P. cepalis

LMG 31106

T

; 9,

P. commovens

LMG 31010

T

;

10,

P. communis

LMG 31110

T

; 11,

P. eparura

LMG 31012

T

; 12,

P. faecigallinarum

LMG 28171

T

; 13,

P. fibrosis

LMG 29626

T

; 14,

P. horticolens

LMG 31112

T

; 15,

P. iniqua

LMG 31009

T

; 16,

P. morbifera

LMG 31116

T

; 17,

P. norimbergensis

LMG 18379

T

; 18,

P. nosoerga

LMG 31109

T

; 19,

P. oxalativorans

LMG 28169

T

; 20,

P. pneumonica

LMG 31114

T

; 21,

P. pnomenusa

LMG 18087

T

; 22,

P. pulmonicola

LMG 18106

T

; 23,

P. soli

LMG 31014

T

; 24,

P. sputorum

LMG 18819

T

; 25,

P. terrae

LMG 30175

T

;

26,

P. terrigena

LMG 31013

T

;

27,

P. thiooxydans

LMG 24779

T

; 28,

P. vervacti

LMG 28170

T

. +, present; −, absent; w, weak reaction.

a

Growth characteristics were recorded after 4 days of incubation, except for

P. thiooxydans

LMG 24779

T

for test results were recorded after 7 days of incubation.

The following biochemical characteristics were shared by all *Pandoraea* strains investigated: growth at 15, 28, and 37°C, but not at 4°C; growth in the presence of 0--4% NaCl, but not in the presence of 6--10% NaCl; growth at pH 6, 7, and 8, but not at pH 4, 5, or 9. No anaerobic growth. Oxidase activity is present. No hydrolysis of starch or casein. No DNase activity. No denitrification. Assimilation of [L]{.smallcaps}-malate, but not [L]{.smallcaps}-arabinose, [D]{.smallcaps}-mannose, [D]{.smallcaps}-mannitol, *N*-acetylglucosamine, maltose or adipate. No fermentation of glucose. No indole production, esculin hydrolysis, arginine dihydrolase, urease or PNP-β-galactosidase activity, or liquefaction of gelatin. Leucine arylamidase activity is present, but no C~8~-ester-lipase, C~14~-lipase, valine or cystine arylamidase, trypsin, chymotrypsin, α-galactosidase, β-galactosidase, β-glucuronidase, α-glucosidase, β-glucosidase, *N*-acetyl-β-glucosaminidase, α-mannosidase or α-fucosidase activity.

An overview of biochemical characteristics useful for distinguishing the type strains of *Pandoraea* species is shown in [Table 3](#T3){ref-type="table"}.

The fatty acid profiles of all type strains are shown in [Table 4](#T4){ref-type="table"}. Both quantitative and qualitative differences were present. The predominant fatty acids in all strains investigated were C~16:0~, C~17:0~ cyclo, C~16:0~ 3-OH, C~18:1~ ω7c, C~19:0~ cyclo ω8c, summed feature 2 (comprising C~14:0~ 3-OH, C~16:1~ iso I, an unidentified fatty acid with equivalent chain length of 10.928, or C~12:0~ ALDE, or any combination of these fatty acids), or summed feature 3 (comprising C~16:1~ ω7c or C~15:0~ iso 2-OH or both).

###### 

Fatty acid composition of all strains examined.

  **Fatty acid**        **1**    **2**    **3**    **4**    **5**    **6**    **7**    **8**    **9**    **10**   **11**   **12**   **13**   **14**
  --------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  C~12:0~               3.40     1.38     3.48     9.30     2.22     3.16     3.48     4.54     9.69     4.42     4.30     2.34     9.07     4.19
  C~12:0~ 2-OH          Tr       1.09     1.99     1.09     1.90     1.30     1.24     ND       Tr       Tr       ND       Tr       1.61     Tr
  C~14:0~               Tr       1.77     1.06     Tr       Tr       Tr       Tr       Tr       Tr       Tr       Tr       1.88     ND       Tr
  C~14:0~ 2-OH          ND       1.01     ND       ND       ND       ND       ND       ND       ND       ND       ND       Tr       ND       ND
  C~16:0~               18.95    20.54    20.21    18.38    23.45    16.09    15.29    15.29    17.76    18.82    15.47    15.77    19.98    17.45
  C~16:0~ 2-OH          1.01     1.13     Tr       Tr       1.01     1.28     1.78     1.21     Tr       1.67     1.22     Tr       ND       1.56
  C~16:0~ 3-OH          6.32     8.46     8.65     7.18     6.98     7.31     8.57     6.39     6.48     9.50     6.82     8.83     5.83     10.96
  C~16:1~ 2-OH          1.29     Tr       4.27     1.08     1.45     2.04     1.99     3.99     Tr       1.76     3.47     5.00     ND       2.76
  C~17:0~ cyclo         19.83    18.78    20.57    13.72    26.44    19.46    20.35    14.29    9.14     18.10    9.52     8.30     2.47     20.72
  C~18:0~               Tr       ND       ND       Tr       ND       Tr       Tr       ND       Tr       Tr       Tr       Tr       Tr       ND
  C~18:1~ 2-OH          3.39     3.35     3.91     3.07     2.49     5.18     5.94     2.71     2.17     3.15     3.54     5.86     ND       3.84
  C~18:1~ ω7c           18.07    13.55    8.90     19.62    10.03    16.95    4.80     17.36    25.76    11.86    25.08    21.23    28.21    4.38
  C~19:0~ cyclo ω8c     13.93    14.04    11.06    8.41     11.84    13.54    23.14    13.82    3.97     13.79    5.93     3.40     Tr       17.86
  Summed feature 2^∗^   7.02     8.64     10.79    9.12     7.70     7.87     9.95     8.22     8.98     9.89     7.87     10.13    7.72     11.65
  Summed feature 3^∗^   3.52     4.12     3.38     8.16     3.05     3.55     1.20     11.01    12.47    4.51     14.42    13.42    22.01    2.22
                                                                                                                                             
  **Fatty acid**        **15**   **16**   **17**   **18**   **19**   **20**   **21**   **22**   **23**   **24**   **25**   **26**   **27**   **28**
                                                                                                                                             
  C~12:0~               8.47     5.15     4.54     ND       3.93     4.18     2.03     3.02     4.31     2.86     5.59     4.35     3.97     4.18
  C~12:0~ 2-OH          1.01     1.51     Tr       ND       Tr       Tr       1.72     1.98     ND       2.23     Tr       ND       ND       Tr
  C~14:0~               Tr       1.19     Tr       1.71     Tr       Tr       Tr       Tr       Tr       Tr       Tr       Tr       Tr       Tr
  C~14:0~ 2-OH          ND       ND       ND       8.27     ND       ND       Tr       ND       ND       ND       2.02     ND       ND       ND
  C~16:0~               18.03    15.83    15.09    14.82    15.40    21.94    18.34    18.19    12.28    17.13    22.91    13.49    26.61    15.72
  C~16:0~ 2-OH          ND       ND       1.06     3.66     1.26     1.61     1.33     1.79     1.67     1.14     ND       1.48     ND       1.16
  C~16:0~ 3-OH          6.82     9.40     7.53     14.18    7.03     7.88     7.90     9.48     3.14     8.64     7.06     6.56     1.84     9.05
  C~16:1~ 2-OH          Tr       1.07     2.41     2.20     4.93     1.35     2.78     2.19     5.96     Tr       2.00     4.84     Tr       3.51
  C~17:0~ cyclo         14.43    4.84     22.11    15.45    11.45    22.81    16.32    16.55    8.49     14.59    8.24     11.33    19.60    19.36
  C~18:0~               Tr       1.41     Tr       ND       Tr       Tr       Tr       Tr       Tr       ND       Tr       Tr       Tr       ND
  C~18:1~ 2-OH          1.61     3.77     3.09     5.69     4.56     2.49     5.19     3.29     3.66     3.99     ND       3.85     Tr       6.58
  C~18:1~ ω7c           21.55    30.31    12.94    1.25     20.47    8.85     17.84    7.05     16.75    21.18    18.83    23.91    12.42    9.54
  C~19:0~ cyclo ω8c     7.75     5.58     14.19    13.03    8.57     14.85    10.16    20.19    3.33     11.56    5.31     5.65     3.12     17.50
  Summed feature 2^∗^   8.63     9.75     10.50    18.27    8.30     9.07     8.49     11.07    12.00    9.87     9.45     8.15     12.29    9.59
  Summed feature 3^∗^   9.10     9.26     3.58     ND       11.51    2.76     5.10     2.19     16.19    4.49     15.15    13.39    15.25    1.94

Species: 1,

P. anapnoica

LMG 31117

T

; 2,

P. anhela

LMG 31108

T

; 3,

P. apista

LMG 16407

T

; 4,

P. aquatica

LMG 31011

T

; 5,

P. bronchicola

LMG 20603

T

; 6,

P. capi

LMG 20602

T

; 7,

P. captiosa

LMG 31118

T

; 8,

P. cepalis

LMG 31106

T

; 9,

P. commovens

LMG 31010

T

;

10,

P. communis

LMG 31110

T

; 11,

P. eparura

LMG 31012

T

; 12,

P. faecigallinarum

LMG 28171

T

; 13,

P. fibrosis

LMG 29626

T

; 14,

P. horticolens

LMG 31112

T

; 15,

P. iniqua

LMG 31009

T

; 16,

P. morbifera

LMG 31116

T

; 17,

P. norimbergensis

LMG 18379

T

; 18,

P. nosoerga

LMG 31109

T

; 19,

P. oxalativorans

LMG 28169

T

; 20,

P. pneumonica

LMG 31114

T

; 21,

P. pnomenusa

LMG 18087

T

; 22,

P. pulmonicola

LMG 18106

T

; 23,

P. soli

LMG 31014

T

; 24,

P. sputorum

LMG 18819

T

; 25,

P. terrae

LMG 30175

T

;

26,

P. terrigena

LMG 31013

T

;

27,

P. thiooxydans

LMG 24779

T

; 28,

P. vervacti

LMG 28170

T

. Those fatty acids for which the amount for all taxa was \<1% are not included, therefore, the percentages may not add up to 100%. Tr, trace amount (\<1%); ND, not detected.

∗

Summed feature 2 comprises iso-C

16:1

I and/or C

14:0

3-OH; summed feature 3 comprises iso-C

15:0

2-OH and/or C

16:1

ω7c.

Functional Genome Analyses {#S3.SS5}
--------------------------

The 68 *Pandoraea* genomes in the present study comprised 331,123 CDS, of which 273,692 (83%) and 128,054 (39%) could be assigned to the COG and KEGG orthologies, respectively ([Supplementary Table S5](#SM4){ref-type="supplementary-material"}). Orthologous genes were identified to determine the conserved genome content of the genus *Pandoraea*. Ortholog analysis revealed 10,783 orthogroups (325,879 CDS) in total, of which 738 (51,633 CDS) were present in all genomes, 897 (62,692 CDS) were present in all genomes except *Ca.* Pandoraea novymonadis, 8,003 (207,937 CDS) were present in multiple species, 1,130 (3,581 CDS) were species-specific and 15 (36 CDS) were isolate-specific ([Figure 3](#F3){ref-type="fig"}). For further analyses, the core orthogroups were defined as those present in all genomes or all genomes except *Ca.* Pandoraea novymonadis (*n* = 1,635). COG and KEGG could be assigned to 7,243 (67%) and 3,655 (34%) of a total of 10,783 orthogroups ([Supplementary Table S6](#SM5){ref-type="supplementary-material"}). A previous pan genome analysis of 36 *Pandoraea* genomes by [@B69] revealed a core genome of 1,903 CDS. As shown by these authors, the pan genome of *Pandoraea* is open ([@B69]) and the number of core genes decreases with an increasing number of genomes analyzed.

![Genomes per orthogroup. Core, present in all genomes or all genomes except *Ca.* Pandoraea novymonadis.](fmicb-10-02556-g003){#F3}

The frequency of orthologous versus non-orthologous CDS varied significantly per isolate \[*X*^2^(67) = 7423, *p* \< 0.001\] and species \[*X*^2^(29) = 5863, *p* \< 0.001\]. The number of non-orthologous CDS per genome ranged from 0 to 632, with *P. terrae* LMG 30175^T^ showing the highest percentage of non-orthologous CDS ([Figure 4](#F4){ref-type="fig"} and [Supplementary Table S7](#SM5){ref-type="supplementary-material"}). To identify biological functions that were over- or underrepresented in the core genome, we looked at the COG and KEGG functional classification of the orthogroups versus their specificity (core, multiple species, single species or single isolate). The specificity of the orthogroups varied significantly among the COG categories \[*X*^2^(66) = 522, *p* \< 0.001\] and highest levels of the KEGG pathways \[*X*^2^(10) = 130, *p* \< 0.001\]. The core orthogroups were significantly enriched in the COG categories Translation, ribosomal structure and biogenesis (J), Posttranslational modification, protein turnover, chaperones (O), Nucleotide transport and metabolism (F) and Coenzyme transport and metabolism (H) ([Figure 5](#F5){ref-type="fig"} and [Supplementary Table S8](#SM5){ref-type="supplementary-material"}) and in the KEGG pathway Genetic Information Processing (09120) ([Figure 6](#F6){ref-type="fig"} and [Supplementary Table S9](#SM5){ref-type="supplementary-material"}).

![The frequency of orthologous versus non-orthologous CDS varies among species. Bar plots show the number of orthologous and non-orthologous CDS per species \[*X*^2^(29) = 5863, *p* \< 0.001\].](fmicb-10-02556-g004){#F4}

![Orthogroup specificity varies among COG categories. Bar plot shows the number of orthogroups and their specificity per COG category \[*X*^2^(66) = 522, *p* \< 0.001\]. J, translation, ribosomal structure and biogenesis; K, transcription; L, replication, recombination and repair; B, chromatin structure and dynamics; D, cell cycle control, cell division, chromosome partitioning; V, defense mechanisms; T, signal transduction mechanisms; M, cell wall/membrane/envelope biogenesis; N, cell motility; W, extracellular structures; U, intracellular trafficking, secretion, and vesicular transport; O, posttranslational modification, protein turnover, chaperones; X, mobilome: prophages, transposons; C, energy production and conversion; G, carbohydrate transport and metabolism; E, amino acid transport and metabolism; F, nucleotide transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism; P, inorganic ion transport and metabolism; Q, secondary metabolites biosynthesis, transport and catabolism; R, general function prediction only; S, function unknown.](fmicb-10-02556-g005){#F5}

![Orthogroup specificity varies among KEGG categories. Bar plot shows the number of orthogroups and their specificity per KEGG category \[*X*^2^(10) = 130, *p* \< 0.001\].](fmicb-10-02556-g006){#F6}

Because many *Pandoraea* strains participate in the biodegradation of recalcitrant xenobiotics ([@B65]; [@B52]; [@B58]; [@B68]; [@B11]; [@B13]; [@B55]; [@B64]; [@B39]; [@B70]; [@B42]; [@B69]), we specifically looked at the orthogroups in the KEGG pathway Xenobiotics biodegradation and metabolism ([Figure 7](#F7){ref-type="fig"}). Most orthogroups in this pathway were present in multiple species (*n* = 28) and some were even present in the core *Pandoraea* genome (*n* = 6). This confirmed the potential of *Pandoraea* for degrading xenobiotics. In particular, the widespread capacity to utilize benzoate derivatives ([Figure 7](#F7){ref-type="fig"}, pathways 362, 364, 627, and 633) explains why several strains have the potential to degrade lignin ([@B58]; [@B38]; [@B42]) and other aromatic compounds ([@B60]; [@B65]; [@B68]). Finally, *P. fibrosis* and *P. thiooxydans* showed a unique capacity to degrade specific compounds ([Figure 7](#F7){ref-type="fig"}). *P. fibrosis* was only recently described and named after its origin from a cystic fibrosis patient ([@B57]) but its unique capacity to degrade nitrotoluene derivatives is yet another example of the versatility in one *Pandoraea* species.

![Orthogroup specificity in KEGG pathway Xenobiotics biodegradation and metabolism. Bar plot shows the number of orthogroups and their specificity.](fmicb-10-02556-g007){#F7}

Conclusion {#S4}
==========

The present study extends the number of formally named *Pandoraea* species considerably and makes reference cultures and their whole-genome sequences publicly available. The genus *Pandoraea* further emerges as a group of environmental bacteria with strong biodegradation capacities and as opportunistic human pathogens, especially in persons with cystic fibrosis. Within this genus, *P. thiooxydans* and *P. terrae* and *Candidatus* P. novymonadis cluster outside the main *Pandoraea* lineage. The aberrant phylogenomic position of the former is further supported by a distinctive phenotype. The classification of these bacteria within this monophyletic genus could therefore be questioned.

Taking into account the source and identification of strains ISTKB (a rhizospheric soil isolate, [@B36]) and B-6 (an eroded bamboo slip isolate, [@B43]), and, to be as comprehensive as possible, also some additional unpublished own data (JL and PV), the novel species *P. aquatica*, *P. capi*, *P. cepalis*, *P. commovens*, *P. communis*, and *P. iniqua*, but also the established species *P. faecigallinarum*, *P. norimbergensis*, *P. pnomenusa*, and *P. fibrosis*, have all been isolated from both human clinical and environmental sources. Thus far, the novel species *P. anapnoica*, *P. anhela*, *P. bronchicola*, *P. captiosa*, *P. morbifera*, *P. nosoerga*, and *P. pneumonica*, but also the established species *P. apista*, *P. pulmonicola*, and *P. sputorum*, have all been isolated from human clinical sources only; while the novel species *P. eparura, P. horticolens, P. soli* and *P. terrigena*, and the established species *P. oxalativorans*, *P. terrae*, *P. thiooxydans*, and *P. vervacti* have thus far been isolated from environmental samples only.

The present study provides genomic, chemotaxonomic and phenotypic data that enable a formal proposal of 17 novel *Pandoraea* species as outlined below. By making reference cultures and whole-genome sequences of each of these versatile bacteria publicly available, we aim to contribute to future knowledge about the metabolic versatility and pathogenicity of these organisms.

Description of *Pandoraea anapnoica* sp. nov. {#S4.SS1}
---------------------------------------------

*Pandoraea anapnoica* sp. nov. (a.na.pnoi'ca. Gr. masc. adj. *anapnoikos*, affecting respiration; N.L. fem. adj. *anapnoica* affecting respiration).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States.

The type strain is LMG 31117^T^ (=CCUG 73385^T^) and was isolated from a cystic fibrosis specimen in the United States in 1999. Its G + C content is 62.4 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31117^T^ are publicly available through the accession numbers [LR536847](LR536847), [LR536866](LR536866)--[LR536868](LR536868), and [CABPSP010000000](CABPSP010000000), respectively.

Description of *Pandoraea anhela* sp. nov. {#S4.SS2}
------------------------------------------

*Pandoraea anhela* sp. nov. (an.he'la. L. fem. adj. *anhela* breath-taking).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States.

The type strain is LMG 31108^T^ (=CCUG 73386^T^) and was isolated from a cystic fibrosis specimen in the United States in 2006. Its G + C content is 63.4 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31108^T^ are publicly available through the accession numbers [LR536848](LR536848), [LR536863](LR536863)-[LR536865](LR536865) and [CABPSB010000000](CABPSB010000000), respectively.

Description of *Pandoraea aquatica* sp. nov. {#S4.SS3}
--------------------------------------------

*Pandoraea aquatica* sp. nov. (a.qua'ti.ca. L. fem. adj. *aquatica* aquatic).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States and from pond water in Belgium.

The type strain is LMG 31011^T^ (=CCUG 73384^T^) and was isolated from pond water in a greenhouse in Belgium in 2013. Its G + C content is 62.9 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31011^T^ are publicly available through the accession numbers [LR536849](LR536849), [LR536869](LR536869)--[LR536871](LR536871), and [CABPSN010000000](CABPSN010000000), respectively.

Description of *Pandoraea bronchicola* sp. nov. {#S4.SS4}
-----------------------------------------------

*Pandoraea bronchicola* sp. nov. (bron.chi'co.la. L. neut. pl. n. *bronchia*, the bronchial tubes; L. suff. -*cola* \[from L. n. *incola*\] a dweller, inhabitant; N.L. fem. n. *bronchicola* a dweller of bronchi, coming from the bronchi).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States.

The type strain is LMG 20603^T^ (= ATCC BAA-110^T^ = CDC H652^T^) and was isolated from cystic fibrosis sputum in the United States in 1998. Its G + C content is 63.0 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 20603^T^ are publicly available through the accession numbers [LR536994](LR536994), [LR536872](LR536872)--[LR536874](LR536874), and [CABPST010000000](CABPST010000000), respectively.

Description of *Pandoraea capi* sp. nov. {#S4.SS5}
----------------------------------------

*Pandoraea capi* sp. nov. (ca'pi. Gr. masc. n. *kapos*, breath; N.L. gen. n. *capi*, referring to the lung as niche of these bacteria).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States and from rhizospheric soil in India.

The type strain is LMG 20602^T^ (=ATCC BAA-109^T^ = CDC G9805^T^) and was isolated from sputum of a non-cystic fibrosis patient in the United States in 1996. Its G + C content is 63.4 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 20602^T^ are publicly available through the accession numbers [LR536850](LR536850), [LR536884](LR536884)--[LR536886](LR536886), and [CABPRV010000000](CABPRV010000000), respectively.

Description of *Pandoraea captiosa* sp. nov. {#S4.SS6}
--------------------------------------------

*Pandoraea captiosa* sp. nov. (cap.ti.o'sa. L. fem. adj. *captiosa*, harmful, disadvantageous).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States.

The type strain is LMG 31118^T^ (=CCUG 73387^T^) and was isolated from a cystic fibrosis specimen in the United States in 2008. Its G + C content is 63.3 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31118^T^ are publicly available through the accession numbers [LR536851](LR536851), [LR536893](LR536893)--[LR536895](LR536895), and [CABPSQ010000000](CABPSQ010000000), respectively.

Description of *Pandoraea cepalis* sp. nov. {#S4.SS7}
-------------------------------------------

*Pandoraea cepalis* sp. nov. \[ce.pa'lis. Gr. n. *kepos*, garden; *-alis* L. adjective forming suffix, pertaining to; N.L. fem. adj. *cepalis* pertaining to garden (soil)\].

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from soil and water samples in Belgium and the Netherlands, from human clinical samples in the United States, and from historical bamboo slips in China.

The type strain is LMG 31106^T^ (=CCUG 39680^T^) and was isolated from garden soil in The Netherlands. Its G + C content is 63.7 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31106^T^ are publicly available through the accession numbers [LR536852](LR536852), [LR536896](LR536896)--[LR536898](LR536898), and [CABPSL010000000](CABPSL010000000), respectively.

Description of *Pandoraea commovens* sp. nov. {#S4.SS8}
---------------------------------------------

*Pandoraea commovens* sp. nov. (com.mo'vens. L. v. *commovere*, to trouble, upset; L. pres. part. *commovens* troubling).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in Belgium and the United States, from soil samples in Belgium, and from plant roots in India.

The type strain is LMG 31010^T^ (=CCUG 73378^T^) and was isolated from sputum of a cystic fibrosis patient in Belgium in 2002. Its G + C content is 62.6 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31010^T^ are publicly available through the accession numbers [LR536853](LR536853), [LR536902](LR536902)--[LR536904](LR536904), and [CABPSA010000000](CABPSA010000000), respectively.

Description of *Pandoraea communis* sp. nov. {#S4.SS9}
--------------------------------------------

*Pandoraea communis* sp. nov. (com.mu'nis. L. fem. adj. *communis* common, widespread).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical, soil and water samples in Belgium, and from soil in Australia.

The type strain is LMG 31110^T^ (=CCUG 73383^T^) and was isolated from sputum of a cystic fibrosis patient in Belgium in 2012. Its G + C content is 62.6 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31110^T^ are publicly available through the accession numbers [LR536854](LR536854), [LR536911](LR536911)-[LR536913](LR536913) and [CABPSJ010000000](CABPSJ010000000), respectively.

Description of *Pandoraea eparura* sp. nov. {#S4.SS10}
-------------------------------------------

*Pandoraea eparura* sp. nov. (ep.a.ru'ra. Gr. masc. adj. *eparouros*, attached to the soil; N.L. fem. adj. *eparura* attached to the soil).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

The type (and thus far only) strain is LMG 31012^T^ (=CCUG 73380^T^) and was isolated from soil of a house plant in Belgium in 2003. Its G + C content is 63.7 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31012^T^ are publicly available through the accession numbers [LR536855](LR536855), [LR536923](LR536923)--[LR536925](LR536925), and [CABPSH010000000](CABPSH010000000), respectively.

Description of *Pandoraea horticolens* sp. nov. {#S4.SS11}
-----------------------------------------------

*Pandoraea horticolens* sp. nov. (hor.ti'co.lens. L. n. *hortus* garden; L. v. *colere* to dwell; L. pres. part. *colens* dwelling; N.L. part. adj. *horticolens* because the type strain was isolated from garden \[soil\]).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

The type (and thus far only) strain is LMG 31112^T^ (=CCUG 73379^T^) and was isolated from garden soil in Belgium in 2003. Its G + C content is 62.3 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31112^T^ are publicly available through the accession numbers [LR536857](LR536857), [LR536926](LR536926)-[LR536928](LR536928) and [CABPSM010000000](CABPSM010000000), respectively.

Description of *Pandoraea iniqua* sp. nov. {#S4.SS12}
------------------------------------------

*Pandoraea iniqua* sp. nov. (in.i'qua. L. fem. adj. *iniqua* disadvantageous, hostile).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from soil samples in Belgium and human clinical samples in the United States.

The type strain is LMG 31009^T^ (=CCUG 73377^T^) and was isolated from maize rhizosphere soil in Belgium in 2002. Its G + C content is 63.1 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31009^T^ are publicly available through the accession numbers [LR536856](LR536856), [LR536929](LR536929)--[LR536931](LR536931), and [CABPSF010000000](CABPSF010000000), respectively.

Description of *Pandoraea morbifera* sp. nov. {#S4.SS13}
---------------------------------------------

*Pandoraea morbifera* sp. nov. (mor.bi'fe.ra, L. fem. adj. *morbifera* that brings disease).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in the United States.

The type strain is LMG 31116^T^ (=CCUG 73389^T^) and was isolated from a cystic fibrosis specimen in the United States in 2006. Its G + C content is 64.7 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31116^T^ are publicly available through the accession numbers [LR536858](LR536858), [LR536935](LR536935)--[LR536937](LR536937), and [CABPSD010000000](CABPSD010000000), respectively.

Description of *Pandoraea nosoerga* sp. nov. {#S4.SS14}
--------------------------------------------

*Pandoraea nosoerga* sp. nov. (no.so.er'ga, Gr. masc. adj. *nosoergos*, causing sickness; N.L. fem. adj. *nosoerga*).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

Isolated from human clinical samples in Australia, Belgium, Germany, United Kingdom and the United States.

The type strain is LMG 31109^T^ (=CCUG 73390^T^) and was isolated from a cystic fibrosis specimen in the United States in 2008. Its G + C content is 66.1 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31109^T^ are publicly available through the accession numbers [LR536859](LR536859), [LR536941](LR536941)-[LR536943](LR536943) and [CABPSC010000000](CABPSC010000000), respectively.

Description of *Pandoraea pneumonica* sp. nov. {#S4.SS15}
----------------------------------------------

*Pandoraea pneumonica* sp. nov. (pneu.mo'ni.ca, Gr. masc. adj. *pneumonikos*, of the lungs; N.L. fem. adj. *pneumonica*).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

The type (and thus far only) strain is LMG 31114^T^ (=CCUG 73388^T^) and was isolated from a cystic fibrosis specimen in the United States in 2009. Its G + C content is 62.5 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31114^T^ are publicly available through the accession numbers [LR536861](LR536861), [LR536974](LR536974)--[LR536976](LR536976), and [CABPSK010000000](CABPSK010000000), respectively.

Description of *Pandoraea soli* sp. nov. {#S4.SS16}
----------------------------------------

*Pandoraea soli* sp. nov. (so'li. L. gen. n. *soli* of soil, the source of the type strain).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

The type (and thus far only) strain is LMG 31014^T^ (=CCUG 73382^T^) and was isolated from soil of a house plant in Belgium in 2003. Its G + C content is 63.6 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31014^T^ are publicly available through the accession numbers [LR536860](LR536860), [LR536980](LR536980)--[LR536982](LR536982), and [CABPSG010000000](CABPSG010000000), respectively.

Description of *Pandoraea terrigena* sp. nov. {#S4.SS17}
---------------------------------------------

*Pandoraea terrigena* sp. nov. (ter.ri'ge.na. L. fem. n. *terra* soil; L. v. *gignere* to bear; L. fem. n. *terrigena* \[nominative in apposition\] born of, or from, soil, soil-born).

The phenotypic description is as presented above and in [Table 3](#T3){ref-type="table"}.

The type (and thus far only) strain is LMG 31013^T^ (=CCUG 73381^T^) and was isolated from soil of a house plant in Belgium in 2003. Its G + C content is 63.5 mol% (calculated based on its genome sequence). The 16S rRNA, *gltB*, *gyrB*, *recA* and whole-genome sequence of LMG 31013^T^ are publicly available through the accession numbers [LR536862](LR536862), [LR536977](LR536977)--[LR536979](LR536979), and [CABPRU010000000](CABPRU010000000), respectively.
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